Literature DB >> 12009023

Use of a phage display technique to identify potential osteoblast binding sites within osteoclast lacunae.

Tzong-Jen Sheu1, Edward M Schwarz, Regis J O'Keefe, Randy N Rosier, J Edward Puzas.   

Abstract

There is a temporal coupling between the processes of bone resorption and bone formation in normal skeletal remodeling. That is, osteoblastic activity usually follows episodes of osteoclastic activity. However, what has not been universally appreciated is that there also is a spatial coupling between these processes. Bone formation only occurs in the immediate vicinity of the resorptive event. In this study, we describe a phage display technique that has been used to identify the mechanisms by which osteoblasts recognize components of the prior resorbed lacunar surface. Using a type V tartrate-resistant acid phosphatase (TRAP) as the bait and a random peptide M13 phage display library as the probe, we have identified specific sequences that show a very high affinity for TRAP. One of these peptides, designated clone 5, has a subnanomolar Kd for TRAP, interacts with TRAP in a Far-Western assay, binds exclusively to TRAP within osteoclast lacunae, is present in osteoblasts, and can effectively block osteoblast binding to resorption surfaces. The clone 5 peptide shows a high homology to glypican 4 (GPC4), a proteoglycan attachment receptor found in a number of cell types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009023     DOI: 10.1359/jbmr.2002.17.5.915

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues.

Authors:  Maureen R Newman; Steven G Russell; Christopher S Schmitt; Ian A Marozas; Tzong-Jen Sheu; J Edward Puzas; Danielle S W Benoit
Journal:  Biomacromolecules       Date:  2017-12-28       Impact factor: 6.988

2.  Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts.

Authors:  Mohamed Essameldin Abdelgawad; Jean-Marie Delaisse; Maja Hinge; Pia Rosgaard Jensen; Ragad Walid Alnaimi; Lars Rolighed; Lars H Engelholm; Niels Marcussen; Thomas Levin Andersen
Journal:  Histochem Cell Biol       Date:  2016-02-09       Impact factor: 4.304

3.  TRIP-1: a regulator of osteoblast function.

Authors:  Diana Metz-Estrella; Jennifer H Jonason; Tzong-Jen Sheu; Rachel M Mroczek-Johnston; J Edward Puzas
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

4.  Loss of trabeculae by mechano-biological means may explain rapid bone loss in osteoporosis.

Authors:  Brianne M Mulvihill; Laoise M McNamara; Patrick J Prendergast
Journal:  J R Soc Interface       Date:  2008-10-06       Impact factor: 4.118

Review 5.  Local and targeted drug delivery for bone regeneration.

Authors:  Maureen R Newman; Danielle Sw Benoit
Journal:  Curr Opin Biotechnol       Date:  2016-04-08       Impact factor: 9.740

6.  Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.

Authors:  Yuchen Wang; Maureen R Newman; Marian Ackun-Farmmer; Michael P Baranello; Tzong-Jen Sheu; J Edward Puzas; Danielle S W Benoit
Journal:  ACS Nano       Date:  2017-09-13       Impact factor: 15.881

7.  Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling.

Authors:  Rama Garimella; Sarah E Tague; Jianghong Zhang; Frank Belibi; Niru Nahar; Ben Hua Sun; Karl Insogna; Jinxi Wang; H Clarke Anderson
Journal:  J Histochem Cytochem       Date:  2008-03-03       Impact factor: 2.479

Review 8.  The reversal phase of the bone-remodeling cycle: cellular prerequisites for coupling resorption and formation.

Authors:  Jean-Marie Delaisse
Journal:  Bonekey Rep       Date:  2014-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.